Your new post is loading...
Your new post is loading...
|
Gerd Moe-Behrens's comment,
May 25, 2013 10:54 AM
Great project. Do what burn for. I will send you later some info by mail. CytoComop is at the present in the seed phase with two openings for additional cofounders, one with a background in synthetic biology and one electric engineering. People who are interested to discuss this project are always welcome. Next year we will be able to offer positions for early employees. Looking forward to discuss with you.
|
by
Timothy K. Lu, Jayson Bowers and Michael S. Koeris
"Synthetic biology is an emerging engineering field focused on designing artificial biological systems with novel functionalities for use in therapeutics, basic science, biotechnology, and diagnostics [1,2]. Continuous advancements in DNA synthesis and sequencing technologies coupled with new techniques for genomic modification and assembly have opened the door for harnessing the power and diversity of biology for applications. For example, natural bacteriophage products, such as ListShield (Intralytix) and Agriphage (Omnilytics), are commercially available for reducing unwanted bacterial contamination. Natural bacteriophages can be genetically modified to deliver engineered payloads into bacteria, thus selectively functionalizing target bacterial populations to produce active biomolecules. This strategy can endow bacteriophages with the ability to efficiently destroy bacterial biofilms or increase the bactericidal efficacy of antibiotics used in combination with phages by many orders of magnitude [3]. In addition, bacteriophages can be engineered as near-real-time microbial diagnostics by using them to transform target bacteria into factories for detectable molecules..."
http://bit.ly/114egWn